PRTK(Delisted)
Paratek PharmaceuticalsยทNASDAQ
--
--(--)
PRTK Profile
Paratek Pharmaceuticals, Inc.
A commercial-stage biopharmaceutical company that develops innovative antibacterial therapeutics based upon teracycline chemistry
75 Park Plaza, Boston, MA 02116
--
Founded in 2001 as Novacea, Paratek Pharmaceuticals, Inc., located in Delaware, is a specialized pharmaceutical company focused on the development and sale of proprietary products that address important therapeutic needs in the field of neuropathy. The company's goal is to become a leading developer and marketer of pharmaceutical products to meet the therapeutic needs in the field of neurology, with the company's initial focus on psychiatry. The Company's partnership with Purdue Pharma gives the Company the potential to develop its own specialized sales and marketing capabilities in the United States, primarily to market Intermezzo products to psychiatric patients and other products developed to address unmet needs in the field of neuropathy. The company's goal is to develop its own sales and promotion infrastructure, and to start business operations that can be further supported by the successful research and development of TO-2061 and the licensing of other products of the company.
